journal article·2022-10Open access

Protein Binding Nanoparticles as an Integrated Platform for Cancer Diagnosis and Treatment

Xuemei Wang, Shengbo Li, Siqi Wang, Shuo Zheng, Zhenbing Chen, Heng Song

Advanced Science· Volume 9· Issue 29

Abstract

Abstract Smart nanomaterials constitute a new approach toward safer and more effective combined anti‐cancer immunotherapy. In this study, polydopamine‐multiprotein conjugates (DmPCs) that can be used for targeted delivery of multiple proteins to cells, realize imaging and combine the advantages of multiple treatment methods (photothermal therapy, chemodynamic therapy, and immunotherapy) can be synthesized and characterized. Proteins, as biological agents, are frequently used in this context, given their low toxicity in vivo. To overcome protein instability and short half‐life in vivo, the use of several proteins in combination with selected nanomaterials to treat patients with melanoma is proposed. In addition to the synthesis and characterization of protein‐bound nanoparticles, it is further demonstrated that several proteins can be efficiently delivered to tumor sites. DmPCs have a wide range of potential adaptability, which provides new opportunities for proteins in the field of treatment and imaging.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry and Molecular Science Key Laboratory of Combinatorial Biosynthesis and Drug Discovery Wuhan University Wuhan 430072 China

Department of Hand Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (39)

Show source-provided references
1. 10.1002/adma.20200763010.1002/adma.202007630 ↗
2. Lindner S. E. · Adv. Funct. Mater. · 2020 · 6 · aaz3223
3. 10.1111/j.1600-065X.2008.00662.x10.1111/j.1600-065X.2008.00662.x ↗
4. 10.1111/1759-7714.1386710.1111/1759-7714.13867 ↗
5. 10.2174/187152062066620070319165310.2174/1871520620666200703191653 ↗
6. 10.1002/sstr.20200002610.1002/sstr.202000026 ↗
7. 10.1021/acs.nanolett.1c0278210.1021/acs.nanolett.1c02782 ↗
8. 10.1002/adfm.20191067610.1002/adfm.201910676 ↗
9. 10.1002/advs.20190010110.1002/advs.201900101 ↗
10. 10.1039/C8CS00618K10.1039/C8CS00618K ↗
11. 10.1002/ange.20191147710.1002/ange.201911477 ↗
12. 10.1016/j.chempr.2019.05.01310.1016/j.chempr.2019.05.013 ↗
13. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
14. 10.1016/j.chempr.2019.06.00310.1016/j.chempr.2019.06.003 ↗
15. 10.1038/s41565-019-0406-110.1038/s41565-019-0406-1 ↗
16. 10.1021/acsnano.1c0007610.1021/acsnano.1c00076 ↗
17. 10.1039/D0NR08831E10.1039/D0NR08831E ↗
18. 10.1002/anie.20210310610.1002/anie.202103106 ↗
19. 10.1002/anie.20090191610.1002/anie.200901916 ↗
20. 10.1021/acs.bioconjchem.0c0011810.1021/acs.bioconjchem.0c00118 ↗
21. 10.1039/C9NR01904A10.1039/C9NR01904A ↗
22. 10.1002/adfm.20190009510.1002/adfm.201900095 ↗
23. 10.1002/adma.20120468310.1002/adma.201204683 ↗
24. 10.1021/acs.nanolett.0c0312710.1021/acs.nanolett.0c03127 ↗
25. 10.1002/ange.20201687210.1002/ange.202016872 ↗
26. 10.1002/adfm.20200973310.1002/adfm.202009733 ↗
27. 10.1126/science.109583310.1126/science.1095833 ↗
28. 10.1021/acs.chemrev.5b0004610.1021/acs.chemrev.5b00046 ↗
29. 10.1002/smll.20200819810.1002/smll.202008198 ↗
30. 10.2217/nnm.13.11810.2217/nnm.13.118 ↗
31. 10.1021/nn900002m10.1021/nn900002m ↗
32. 10.2174/138920021966618051115235010.2174/1389200219666180511152350 ↗
33. 10.1089/cbr.2017.225310.1089/cbr.2017.2253 ↗
34. 10.1002/adfm.20190771610.1002/adfm.201907716 ↗
35. 10.1002/adfm.20191008510.1002/adfm.201910085 ↗
36. 10.1002/adma.20180832510.1002/adma.201808325 ↗
37. 10.1002/adma.20200689210.1002/adma.202006892 ↗
38. Ke W. · ACS Nano · 2019 · 13 · 2357
39. 10.1002/adfm.20200973310.1002/adfm.202009733 ↗